908 Devices Inc. (MASS)
NASDAQ: MASS · Real-Time Price · USD
9.14
+0.23 (2.58%)
At close: Oct 8, 2025, 4:00 PM EDT
9.15
+0.01 (0.11%)
After-hours: Oct 8, 2025, 4:00 PM EDT
908 Devices Market Cap
908 Devices has a market cap or net worth of $329.82 million as of October 8, 2025. Its market cap has increased by 158.61% in one year.
Market Cap
329.82M
Enterprise Value
210.62M
1-Year Change
158.61%
Ranking
Category
Stock Price
$9.14
Market Cap Chart
Since December 18, 2020, 908 Devices's market cap has decreased from $1.28B to $329.82M, a decrease of -74.31%. That is a compound annual growth rate of -24.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 321.52M | 319.69% |
| Dec 31, 2024 | 76.61M | -78.91% |
| Dec 29, 2023 | 363.29M | 50.35% |
| Dec 30, 2022 | 241.64M | -69.92% |
| Dec 31, 2021 | 803.26M | -46.17% |
| Dec 31, 2020 | 1.49B | 16.22% |
| Dec 18, 2020 | 1.28B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.36B |
| Johnson & Johnson | 454.91B |
| AbbVie | 411.31B |
| UnitedHealth Group | 329.36B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.52B |